Search

Oluwatosin A. Ogunbiyi

Examiner (ID: 9383, Phone: (571)272-9939 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
1113
Issued Applications
596
Pending Applications
141
Abandoned Applications
402

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18970454 [patent_doc_number] => 20240050546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/028477 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028477 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/028477
VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS Sep 27, 2021 Pending
Array ( [id] => 18893804 [patent_doc_number] => 20240009289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE [patent_app_type] => utility [patent_app_number] => 18/251658 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251658 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251658
THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE Sep 23, 2021 Pending
Array ( [id] => 17334620 [patent_doc_number] => 20220000951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => Lactobacillus Crispatus KBL693 Strain and Use Thereof [patent_app_type] => utility [patent_app_number] => 17/448620 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11095 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/448620
Lactobacillus crispatus KBL693 strain and use thereof Sep 22, 2021 Issued
Array ( [id] => 17312914 [patent_doc_number] => 20210401962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => VACCINE FOR PREVENTION OF NECROTIC ENTERITIS IN POULTRY [patent_app_type] => utility [patent_app_number] => 17/474797 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474797 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/474797
Vaccine for prevention of necrotic enteritis in poultry Sep 13, 2021 Issued
Array ( [id] => 20536812 [patent_doc_number] => 12553883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Methods and uses of microbiome compositions [patent_app_type] => utility [patent_app_number] => 17/472189 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 14 [patent_no_of_words] => 11151 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472189
Methods and uses of microbiome compositions Sep 9, 2021 Issued
Array ( [id] => 18691025 [patent_doc_number] => 20230321213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => OUTER MEMBRANE VESICLES [patent_app_type] => utility [patent_app_number] => 18/025273 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025273 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025273
OUTER MEMBRANE VESICLES Sep 8, 2021 Pending
Array ( [id] => 20179489 [patent_doc_number] => 20250263447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS [patent_app_type] => utility [patent_app_number] => 18/043595 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043595 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043595
OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS Sep 2, 2021 Pending
Array ( [id] => 17383985 [patent_doc_number] => 20220031837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/412550 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/412550
PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS Aug 25, 2021 Abandoned
Array ( [id] => 18690984 [patent_doc_number] => 20230321162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => MICROBIAL STRAINS AND ANTIBIOTICS [patent_app_type] => utility [patent_app_number] => 18/022400 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022400 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022400
Microbial strains and antibiotics Aug 17, 2021 Issued
Array ( [id] => 18691032 [patent_doc_number] => 20230321222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Immune Adjuvant Comprising Hepatitis B Virus-Derived Polypeptide [patent_app_type] => utility [patent_app_number] => 18/021261 [patent_app_country] => US [patent_app_date] => 2021-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021261 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/021261
Immune adjuvant comprising hepatitis B virus-derived polypeptide Aug 11, 2021 Issued
Array ( [id] => 17256848 [patent_doc_number] => 20210369833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => BACTERIAL POLYSACCHARIDE-CONJUGATED CARRIER PROTEINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/399944 [patent_app_country] => US [patent_app_date] => 2021-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399944 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/399944
BACTERIAL POLYSACCHARIDE-CONJUGATED CARRIER PROTEINS AND USE THEREOF Aug 10, 2021 Abandoned
Array ( [id] => 18921446 [patent_doc_number] => 20240024450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => NEISSERIAL SURFACE PROTEIN A (NSPA) VARIANTS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/040134 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040134 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/040134
Neisserial surface protein a (NSPA) variants and methods of use thereof Aug 5, 2021 Issued
Array ( [id] => 18777869 [patent_doc_number] => 11819545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Vaccine for prophylaxis or treatment of an allergen-driven airway pathology [patent_app_type] => utility [patent_app_number] => 17/392066 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4841 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/392066
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology Aug 1, 2021 Issued
Array ( [id] => 18612412 [patent_doc_number] => 20230279144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => ANTI-HER2 ANTIBODY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/007262 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007262 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007262
ANTI-HER2 ANTIBODY AND USE THEREOF Jul 26, 2021 Pending
Array ( [id] => 17312865 [patent_doc_number] => 20210401913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => Treatment of Warts [patent_app_type] => utility [patent_app_number] => 17/378411 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378411 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/378411
Treatment of warts Jul 15, 2021 Issued
Array ( [id] => 18724305 [patent_doc_number] => 20230338439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => COMPOSITION FOR TREATING BRAIN DISEASE COMPRISING PEDIOCOCCUS INOPINATUS OR EXTRACELLULAR VESICLES ISOLATED THEREFROM AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 18/015783 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015783 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015783
COMPOSITION FOR TREATING BRAIN DISEASE COMPRISING PEDIOCOCCUS INOPINATUS OR EXTRACELLULAR VESICLES ISOLATED THEREFROM AS ACTIVE INGREDIENT Jul 12, 2021 Pending
Array ( [id] => 20076289 [patent_doc_number] => 12350324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Streptococcal vaccines [patent_app_type] => utility [patent_app_number] => 18/016298 [patent_app_country] => US [patent_app_date] => 2021-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 30 [patent_no_of_words] => 13768 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016298 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/016298
Streptococcal vaccines Jul 11, 2021 Issued
Array ( [id] => 18647876 [patent_doc_number] => 20230293652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => IMMUNOSTIMULATORY ADJUVANTS [patent_app_type] => utility [patent_app_number] => 18/014581 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -256 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014581 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/014581
IMMUNOSTIMULATORY ADJUVANTS Jul 6, 2021 Pending
Array ( [id] => 18691023 [patent_doc_number] => 20230321211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Genetically engineered live bacteria and methods of constructing the same [patent_app_type] => utility [patent_app_number] => 18/002044 [patent_app_country] => US [patent_app_date] => 2021-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002044 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002044
Genetically engineered live bacteria and methods of constructing the same Jul 4, 2021 Issued
Array ( [id] => 17312758 [patent_doc_number] => 20210401806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/363193 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/363193
Compositions and methods for treatment of vaginal infections Jun 29, 2021 Issued
Menu